Considering that targeting this pathway can reverse chemoresistance properties and re-sensitize cells to platinum treatment, our natural epigenetic compounds may be promising options for improving the clinical outcomes and prognosis of patients with platinum-resistant ovarian cancer by downregulating levels of IL-11 [62]. The gene discussed is IL11; the disease is ovarian cancer.